{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:24:01Z","timestamp":1790774641791,"version":"4.1.0"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01229","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T05:52:37Z","timestamp":1574747557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1"],"prefix":"10.3389","volume":"10","author":[{"given":"Sylvia","family":"Nieuwenhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Okkersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Widomska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. C.","family":"'t Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baziel","family":"van Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Glennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2353\/ajpath.2009.080520","article-title":"Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle","volume":"174","author":"Holt","year":"2009","journal-title":"Am J Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1093\/hmg\/ddh327","article-title":"Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons","volume":"13","author":"Jiang","year":"2004","journal-title":"Hum Mol Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.gde.2017.03.007","article-title":"Myotonic dystrophy: approach to therapy","volume":"44","author":"Thornton","year":"2017","journal-title":"Curr Opin Genet Dev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/hmg\/11.9.1045","article-title":"Identification of transcriptional targets for Six5: implication for the pathogenesis of myotonic dystrophy type 1","volume":"11","author":"Sato","year":"2002","journal-title":"Hum Mol Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1172\/JCI5346","article-title":"DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model","volume":"103","author":"Berul","year":"1999","journal-title":"J Clin Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/dvdy.24240","article-title":"Developmental insights into the pathology of and therapeutic strategies for DM1: back to the basics","volume":"244","author":"Chau","year":"2015","journal-title":"Dev Dyn"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1128\/MCB.25.4.1402-1414.2005","article-title":"Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors","volume":"25","author":"van Herpen","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/hmg\/4.6.1063","article-title":"Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue","volume":"4","author":"Whiting","year":"1995","journal-title":"Hum Mol Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein Atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archneur.55.5.635","article-title":"Personality patterns in patients with myotonic dystrophy","volume":"55","author":"Delaporte","year":"1998","journal-title":"Arch Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0002-9440(10)63894-1","article-title":"Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy","volume":"162","author":"Furling","year":"2003","journal-title":"Am J Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","article-title":"Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms","volume":"1852","author":"Meola","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nbd.2010.02.004","article-title":"Epigenetic changes and non-coding expanded repeats","volume":"39","author":"Nakamori","year":"2010","journal-title":"Neurobiol Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"20130605","DOI":"10.1098\/rsif.2013.0605","article-title":"Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease","volume":"10","author":"Higham","year":"2013","journal-title":"J R Soc Interface"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.2337\/db14-0340","article-title":"Insulin regulates brain function, but how does it get there?","volume":"63","author":"Gray","year":"2014","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1210\/en.2008-1190","article-title":"Insulin-like growth factors and the brain","volume":"149","author":"LeRoith","year":"2008","journal-title":"Endocrinology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrendo.2015.173","article-title":"Impaired insulin action in the human brain: causes and metabolic consequences","volume":"11","author":"Heni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.euroneuro.2014.01.020","article-title":"Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects","volume":"24","author":"Werner","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cell.2015.01.012","article-title":"Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes","volume":"160","author":"Perry","year":"2015","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/obr.12862","article-title":"Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes","volume":"20","author":"Meex","year":"2019","journal-title":"Obes Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"E745","DOI":"10.1152\/ajpendo.00271.2005","article-title":"Effect of insulin on human skeletal muscle protein synthesis is modulated by insulin-induced changes in muscle blood flow and amino acid availability","volume":"291","author":"Fujita","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/dom.13378","article-title":"Biosynthesis, structure, and folding of the insulin precursor protein","volume":"20","author":"Liu","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1210\/er.2004-0024","article-title":"The insulin-like growth factor system and its pleiotropic functions in brain","volume":"26","author":"Russo","year":"2005","journal-title":"Endocr Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/archneurol.2010.227","article-title":"Open-label trial of recombinant human insulin-like growth factor 1\/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1","volume":"68","author":"Heatwole","year":"2011","journal-title":"Arch Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1517\/17425255.4.3.311","article-title":"Mecasermin rinfabate: rhIGF-I\/rhIGFBP-3 complex: iPLEX","volume":"4","author":"Williams","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fendo.2017.00031","article-title":"PPAR-gamma agonists as antineoplastic agents in cancers with dysregulated IGF axis","volume":"8","author":"Vella","year":"2017","journal-title":"Front Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-14-0215","article-title":"Endothelial cells and the IGF system","volume":"54","author":"Bach","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1054\/mehy.2001.1462","article-title":"New antidepressant drugs that do not cross the blood-brain barrier","volume":"58","author":"Manev","year":"2002","journal-title":"Med Hypotheses"},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fncel.2017.00014","article-title":"Insulin-like growth factor 1: at the crossroads of brain development and aging","volume":"11","author":"Wrigley","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1083\/jcb.200108071","article-title":"Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice","volume":"157","author":"Barton","year":"2002","journal-title":"J Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10911-008-9100-x","article-title":"The role of endocrine insulin-like growth factor-I and insulin in breast cancer","volume":"13","author":"Lann","year":"2008","journal-title":"J Mamm Gland Biol Neoplasia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2018.10.012","article-title":"Insulin growth factor 2 (IGF2) as an emergent target in psychiatric and neurological disorders. Review","volume":"18","author":"Pardo","year":"2018","journal-title":"Neurosci Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ebiom.2016.11.035","article-title":"Paternal insulin-like growth factor 2 (Igf2) regulates stem cell activity during adulthood","volume":"15","author":"Barroca","year":"2017","journal-title":"EBioMedicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.brainres.2015.07.002","article-title":"Exogenous insulin-like growth factor 2 administration enhances memory consolidation and persistence in a time-dependent manner","volume":"1622","author":"Lee","year":"2015","journal-title":"Brain Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature09667","article-title":"A critical role for IGF-II in memory consolidation and enhancement","volume":"469","author":"Chen","year":"2011","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.str.2015.04.016","article-title":"Structural congruency of ligand binding to the insulin and insulin\/type 1 insulin-like growth factor hybrid receptors","volume":"23","author":"Menting","year":"2015","journal-title":"Structure"},{"key":"B38","doi-asserted-by":"publisher","first-page":"7911","DOI":"10.1038\/srep07911","article-title":"Specific insulin\/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin","volume":"5","author":"Slaaby","year":"2015","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0178885","DOI":"10.1371\/journal.pone.0178885","article-title":"IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718","volume":"12","author":"Andersen","year":"2017","journal-title":"PLoS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"E1145","DOI":"10.1152\/ajpendo.2000.279.5.E1145","article-title":"IGF-I\/IGFBP-3 binary complex modulates sepsis-induced inhibition of protein synthesis in skeletal muscle","volume":"279","author":"Svanberg","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5546\/aap.2017.eng.391","article-title":"Analysis of acid-labile subunit and its usefulness in pediatrics","volume":"115","author":"Zaidman","year":"2017","journal-title":"Arch Argentinos Pediatr"},{"key":"B42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1172\/JCI117636","article-title":"Intravenously injected insulin-like growth factor (IGF) I\/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats","volume":"95","author":"Zapf","year":"1995","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e03772","DOI":"10.7554\/eLife.03772","article-title":"How IGF-1 activates its receptor","volume":"3","author":"Kavran","year":"2014","journal-title":"eLife"},{"key":"B44","first-page":"147","article-title":"Restricted growth clinical, genetic and molecular aspects","volume-title":"Mannose-6-Phosphate\/Insulin-Like Growth Factor 2 Receptor (M6P\/IGF2-R) in Growth and Disease: A Review.","author":"Lemamy","year":"2016"},{"key":"B45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1203\/01.PDR.0000156369.62787.96","article-title":"Early developmental changes in IGF-I, IGF-II, IGF binding protein-1, and IGF binding protein-3 concentration in the cerebrospinal fluid of children","volume":"58","author":"Bunn","year":"2005","journal-title":"Pediatr Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/ijnp\/pyx007","article-title":"IGFBP2 produces rapid-acting and long-lasting effects in rat models of posttraumatic stress disorder via a novel mechanism associated with structural plasticity","volume":"20","author":"Burgdorf","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1152\/jn.00504.2002","article-title":"A role for myotonic dystrophy protein kinase in synaptic plasticity","volume":"89","author":"Schulz","year":"2003","journal-title":"J Neurophysiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"10227","DOI":"10.1038\/srep10227","article-title":"Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ijc.27622","article-title":"Serum insulin-like, growth factor binding protein-related protein 1 (IGFBP-rP1) and endometrial cancer risk in Chinese women","volume":"132","author":"Zhan","year":"2013","journal-title":"Int J Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"ra92","DOI":"10.1126\/scisignal.2003184","article-title":"IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors","volume":"5","author":"Evdokimova","year":"2012","journal-title":"Sci Signal"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1371\/journal.pone.0001134","article-title":"Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action","volume":"2","author":"Llagostera","year":"2007","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat Genet"},{"key":"B53","first-page":"1","article-title":"Myotonic dystrophy type 1","volume-title":"GeneReviews(R)","author":"Bird","year":"1999"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/CON.0000000000000414","article-title":"The dystrophic and nondystrophic myotonias","volume":"22","author":"Sansone","year":"2016","journal-title":"Continuum"},{"key":"B55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/B978-0-08-045031-5.00015-3","article-title":"Myotonic dystrophy types 1 and 2","volume":"101","author":"Ashizawa","year":"2011","journal-title":"Handb Clin Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/brain\/82.2.221","article-title":"Observations on endocrine function in dystrophia myotonica","volume":"82","author":"Marshall","year":"1959","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1056\/NEJM196710192771602","article-title":"Abnormal insulin secretion in myotonic dystrophy","volume":"277","author":"Huff","year":"1967","journal-title":"N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/jcem-28-7-992","article-title":"Dynamics of insulin secretion in myotonic dystrophy","volume":"28","author":"Huff","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1056\/NEJM196809262791318","article-title":"Insulin levels in myotonic dystrophy","volume":"279","author":"Bundey","year":"1968","journal-title":"N Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1210\/jcem-29-5-684","article-title":"Studies of plasma insulin in myotonic dystrophy","volume":"29","author":"Goden","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1056\/NEJM196901232800423","article-title":"Insulin levels in myotonic dystrophy","volume":"280","author":"Jackson","year":"1969","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/0026-0495(69)90005-5","article-title":"Insulin responses in myotonia dystrophica","volume":"18","author":"Mendelsohn","year":"1969","journal-title":"Metabolism"},{"key":"B63","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/brain\/93.4.731","article-title":"Abnormalities of insulin secretion in dystrophia myotonica","volume":"93","author":"Walsh","year":"1970","journal-title":"Brain"},{"key":"B64","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/00000441-197012000-00004","article-title":"Insulin secretion in myotonic dystrophy","volume":"260","author":"Bird","year":"1970","journal-title":"Am J Med Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2337\/diab.22.4.238","article-title":"Carbohydrate and lipid metabolism in relation to body composition in myotonic dystrophy","volume":"22","author":"Bjorntorp","year":"1973","journal-title":"Diabetes"},{"key":"B66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00005792-197407000-00004","article-title":"Plasma insulin in patients with myotonic dystrophy and their relatives","volume":"53","author":"Barbosa","year":"1974","journal-title":"Medicine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0026-0495(74)90084-5","article-title":"The glycogen synthase system in skeletal muscle of normal humans and patients with myotonic dystrophy: effect of glucose and insulin administration","volume":"23","author":"Nuttall","year":"1974","journal-title":"Metabolism"},{"key":"B68","first-page":"384","article-title":"The direct relationship of proinsulin-insulin hypersecretion to basal serum levels of cholesterol and triglyceride in myotonic dystrophy","volume":"87","author":"Poffenbarger","year":"1976","journal-title":"J Lab Clin Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1210\/jcem-45-4-821","article-title":"The insulin receptor in myotonic dystrophy","volume":"45","author":"Kobayashi","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1210\/jcem-44-3-491","article-title":"Carbohydrate metabolism and insulin resistance in myotonia dystrophica","volume":"44","author":"Tevaarwerk","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"B71","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1172\/JCI109198","article-title":"Decreased insulin sensitivity of forearm muscle in myotonic dystrophy","volume":"62","author":"Moxley","year":"1978","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.410060114","article-title":"Evaluation of insulin receptor in myotonic dystrophy","volume":"6","author":"Festoff","year":"1979","journal-title":"Ann Neurol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1212\/WNL.33.6.679","article-title":"Insulin resistance in patients with myotonic dystrophy","volume":"33","author":"Stuart","year":"1983","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ana.410150208","article-title":"Whole body insulin resistance in myotonic dystrophy","volume":"15","author":"Moxley","year":"1984","journal-title":"Ann Neurol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/archneur.1984.04050180062019","article-title":"Effect of acetazolamide on insulin sensitivity in myotonic disorders","volume":"41","author":"Corbett","year":"1984","journal-title":"Arch Neurol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/brain\/110.2.469","article-title":"The role of insulin resistance in the pathogenesis of myotonic muscular dystrophy","volume":"110","author":"Hudson","year":"1987","journal-title":"Brain"},{"key":"B77","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2337\/diab.36.6.693","article-title":"Lack of rapid enhancement of insulin action after oral glucose challenge in myotonic dystrophy","volume":"36","author":"Moxley","year":"1987","journal-title":"Diabetes"},{"key":"B78","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/0026-0495(90)90304-U","article-title":"Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy","volume":"39","author":"Krentz","year":"1990","journal-title":"Metabolism"},{"key":"B79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000468860","article-title":"Insulin resistance in myotonic dystrophy","volume":"45","author":"Piccardo","year":"1991","journal-title":"Enzyme"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/BF00401372","article-title":"Hyperproinsulinaemia in patients with myotonic dystrophy","volume":"35","author":"Krentz","year":"1992","journal-title":"Diabetologia"},{"key":"B81","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/BF00207479","article-title":"Study on growth hormone and insulin secretion in myotonic dystrophy","volume":"72","author":"Gomez Saez","year":"1994","journal-title":"Clin Investig"},{"key":"B82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0960-8966(97)00144-2","article-title":"Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon","volume":"8","author":"Annane","year":"1998","journal-title":"Neuromuscul Disord."},{"key":"B83","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/eje.0.1460397","article-title":"Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy","volume":"146","author":"Johansson","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2337\/diacare.26.7.2112","article-title":"Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy","volume":"26","author":"Perseghin","year":"2003","journal-title":"Diabetes Care"},{"key":"B85","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/ajcn\/80.2.357","article-title":"Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1","volume":"80","author":"Perseghin","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"B86","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jns.2008.08.037","article-title":"A cross-sectional study for glucose intolerance of myotonic dystrophy","volume":"276","author":"Matsumura","year":"2009","journal-title":"J Neurol Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1600-0404.2009.01237.x","article-title":"Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1","volume":"121","author":"Rakocevic Stojanovic","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"B88","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1055\/s-2001-18576","article-title":"Insulin resistance: definition and consequences","volume":"109","author":"Lebovitz","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B89","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"B90","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/1570161114666161007164510","article-title":"Link between metabolic syndrome and insulin resistance","volume":"15","author":"Gluvic","year":"2017","journal-title":"Curr Vasc Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mus.24540","article-title":"Metabolic syndrome in patients with myotonic dystrophy type 1","volume":"52","author":"Vujnic","year":"2015","journal-title":"Muscle Nerve"},{"key":"B92","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2174\/138920211795677912","article-title":"Alstrom syndrome: genetics and clinical overview","volume":"12","author":"Marshall","year":"2011","journal-title":"Curr Genomics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.arr.2016.03.002","article-title":"Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions","volume":"33","author":"Oshima","year":"2017","journal-title":"Ageing Res Rev"},{"key":"B94","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0002-9343(00)00715-4","article-title":"Molecular biology and the prolonged QT syndromes","volume":"110","author":"Towbin","year":"2001","journal-title":"Am J Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.arr.2016.08.002","article-title":"Cockayne syndrome: clinical features, model systems and pathways","volume":"33","author":"Karikkineth","year":"2017","journal-title":"Ageing Res Rev"},{"key":"B96","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/pai.13020","article-title":"Ataxia-telangiectasia: a review of clinical features and molecular pathology","volume":"30","author":"Amirifar","year":"2019","journal-title":"Pediatr Allergy Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fneur.2018.00601","article-title":"Myotonic dystrophy-a progeroid disease?","volume":"9","author":"Meinke","year":"2018","journal-title":"Front Neurol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fnagi.2015.00125","article-title":"Muscle wasting in myotonic dystrophies: a model of premature aging","volume":"7","author":"Mateos-Aierdi","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nmd.2016.11.004","article-title":"Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis","volume":"27","author":"Campione","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/gerona\/gls145","article-title":"Insulin resistance and aging: a cause or a protective response?","volume":"67","author":"Barzilai","year":"2012","journal-title":"J Gerontol A"},{"key":"B101","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ene.13763","article-title":"Survival patterns and cancer determinants in families with myotonic dystrophy type 1","volume":"26","author":"Best","year":"2019","journal-title":"Eur J Neurol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mayocp.2011.09.005","article-title":"Increased cancer risks in myotonic dystrophy","volume":"87","author":"Win","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"key":"B104","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cmet.2012.04.010","article-title":"Lipid-induced mitochondrial stress and insulin action in muscle","volume":"15","author":"Muoio Deborah","year":"2012","journal-title":"Cell Metab"},{"key":"B105","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0022-510X(86)90110-3","article-title":"\u201cRagged-red\u201d fibres in myotonic dystrophy","volume":"74","author":"Ono","year":"1986","journal-title":"J Neurol Sci"},{"key":"B106","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcsm.12178","article-title":"Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue","volume":"8","author":"Boengler","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B107","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1038\/s41598-019-45858-w","article-title":"Improved quantification of muscle insulin sensitivity using oral glucose tolerance test data: the MISI calculator","volume":"9","author":"O'Donovan","year":"2019","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fendo.2018.00002","article-title":"Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links","volume":"9","author":"De Rosa","year":"2018","journal-title":"Front Endocrinol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/emm.2015.3","article-title":"Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome","volume":"47","author":"Kim","year":"2015","journal-title":"Exp Mol Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Archiv Toxicol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamaneurol.2017.4778","article-title":"Development and validation of a new scoring system to predict survival in patients with myotonic dystrophy type 1","volume":"75","author":"Wahbi","year":"2018","journal-title":"JAMA Neurol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"6069","DOI":"10.1093\/nar\/gky401","article-title":"Alternative splicing analysis in human monocytes and macrophages reveals MBNL1 as major regulator","volume":"46","author":"Liu","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B114","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-981-13-0508-5_10","article-title":"Edited by Masanori P. Takahashi TM. Lipid metabolism in myotonic dystrophy: disease mechanism, current management and therapeutic development","volume-title":"Myotonic Dystrophy.","author":"Takada","year":"2018"},{"key":"B115","doi-asserted-by":"publisher","first-page":"14361","DOI":"10.1523\/JNEUROSCI.3171-11.2011","article-title":"Metabolic dysfunction associated with adiponectin deficiency enhances kainic acid-induced seizure severity","volume":"31","author":"Lee","year":"2011","journal-title":"J Neurosci"},{"key":"B116","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cytogfr.2016.10.003","article-title":"Myokines and adipokines: involvement in the crosstalk between skeletal muscle and adipose tissue","volume":"33","author":"Li","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"B117","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/mus.22099","article-title":"Regional body composition and functional impairment in patients with myotonic dystrophy","volume":"44","author":"Pruna","year":"2011","journal-title":"Muscle Nerve"},{"key":"B118","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1212\/WNL.42.1.91","article-title":"Decreased cerebral glucose utilization in myotonic dystrophy","volume":"42","author":"Fiorelli","year":"1992","journal-title":"Neurology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00032.2015","article-title":"Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans","volume":"96","author":"Kullmann","year":"2016","journal-title":"Physiol Rev"},{"key":"B120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1017\/S0317167100012932","article-title":"Prevalence of lifestyle risk factors in myotonic dystrophy type 1","volume":"40","author":"Gagnon","year":"2013","journal-title":"Can J Neurol Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12883-015-0401-6","article-title":"Prevalence and correlates of apathy in myotonic dystrophy type 1","volume":"15","author":"Gallais","year":"2015","journal-title":"BMC Neurol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000478049","article-title":"Insulin signaling deficiency produces immobility in caenorhabditis elegans that models diminished motivation states in man and responds to antidepressants","volume":"3","author":"Dagenhardt","year":"2017","journal-title":"Mol Neuropsychiatry"},{"key":"B123","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cortex.2017.08.008","article-title":"The cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysis","volume":"95","author":"Okkersen","year":"2017","journal-title":"Cortex"},{"key":"B124","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jad.2019.03.036","article-title":"Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis","volume":"250","author":"van der Velden","year":"2019","journal-title":"J Affect Disord"},{"key":"B125","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JND-180310","article-title":"A review of psychopathology features, personality, and coping in myotonic dystrophy type 1","volume":"5","author":"Minier","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"B126","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1503\/jpn.140327","article-title":"An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder","volume":"41","author":"van de Vondervoort","year":"2016","journal-title":"J Psychiatry Neurosci"},{"key":"B127","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41398-019-0559-6","article-title":"Converging evidence points towards a role of insulin signaling in regulating compulsive behavior","volume":"9","author":"van de Vondervoort","year":"2019","journal-title":"Transl Psychiatry"},{"key":"B128","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fneur.2018.00646","article-title":"Current progress in CNS imaging of myotonic dystrophy","volume":"9","author":"Minnerop","year":"2018","journal-title":"Front Neurol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/WNL.0000000000004300","article-title":"Brain imaging in myotonic dystrophy type 1: a systematic review","volume":"89","author":"Okkersen","year":"2017","journal-title":"Neurology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11011-017-9980-9","article-title":"Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients","volume":"32","author":"Hawkins","year":"2017","journal-title":"Metab Brain Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1126\/science.1081203","article-title":"Axons guided by insulin receptor in Drosophila visual system","volume":"300","author":"Song","year":"2003","journal-title":"Science"},{"key":"B132","doi-asserted-by":"publisher","first-page":"101615","DOI":"10.1016\/j.nicl.2018.101615","article-title":"Structural white matter networks in myotonic dystrophy type 1","volume":"21","author":"van Dorst","year":"2019","journal-title":"Neuroimage Clin"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1007\/s00415-013-6984-1","article-title":"Vitamin D deficiency in myotonic dystrophy type 1","volume":"260","author":"Terracciano","year":"2013","journal-title":"J Neurol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature08983","article-title":"Neural mechanisms of ageing and cognitive decline","volume":"464","author":"Bishop","year":"2010","journal-title":"Nature"},{"key":"B135","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.278.5337.419","article-title":"The endocrinology of aging","volume":"278","author":"Lamberts","year":"1997","journal-title":"Science"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/brain\/awy231","article-title":"Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial","volume":"141","author":"Bassez","year":"2018","journal-title":"Brain."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1038\/mtna.2015.35","article-title":"In vitro and in vivo modulation of alternative splicing by the biguanide metformin","volume":"4","author":"Laustriat","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"B138","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1464-5491.2005.01432.x","article-title":"Low-dose metformin improves hyperglycaemia related to myotonic dystrophy","volume":"22","author":"Kouki","year":"2005","journal-title":"Diabet Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1210\/jcem.80.12.8530624","article-title":"Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy\u2013a clinical research center study","volume":"80","author":"Vlachopapadopoulou","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B140","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ana.20460","article-title":"Aerobic training in patients with myotonic dystrophy type 1","volume":"57","author":"Orngreen","year":"2005","journal-title":"Ann Neurol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2340\/16501977-0833","article-title":"Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study","volume":"43","author":"Kierkegaard","year":"2011","journal-title":"J Rehabil Med"},{"key":"B142","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1474-4422(18)30203-5","article-title":"Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial","volume":"17","author":"Okkersen","year":"2018","journal-title":"Lancet Neurol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1210\/jcem-49-2-216","article-title":"Studies on insulin resistance and insulin receptor binding in myotonia dystrophica","volume":"49","author":"Tevaarwerk","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"B144","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1073\/pnas.78.4.2567","article-title":"Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy","volume":"78","author":"Moxley","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"B145","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0022-510X(81)90130-1","article-title":"Glucose transport and oxidation in adipose tissue of patients with myotonic dystrophy","volume":"52","author":"Mably","year":"1981","journal-title":"J Neurol Sci"},{"key":"B146","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0022-510X(83)90223-X","article-title":"Insulin binding to myotonic dystrophy fibroblasts","volume":"58","author":"Lam","year":"1983","journal-title":"J Neurol Sci"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1172\/JCI119332","article-title":"RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance","volume":"99","author":"Morrone","year":"1997","journal-title":"J Clin Invest"},{"key":"B148","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1210\/endo.140.9.7057","article-title":"Insulin-like growth factor I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells","volume":"140","author":"Furling","year":"1999","journal-title":"Endocrinology"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.bbadis.2007.08.004","article-title":"DM1 CTG expansions affect insulin receptor isoforms expression in various tissues of transgenic mice","volume":"1772","author":"Guiraud-Dogan","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B150","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11010-013-1681-z","article-title":"Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2","volume":"380","author":"Santoro","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"B151","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.braindev.2014.11.001","article-title":"Resveratrol enhances splicing of insulin receptor exon 11 in myotonic dystrophy type 1 fibroblasts","volume":"37","author":"Takarada","year":"2015","journal-title":"Brain Dev"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e0184987","DOI":"10.1371\/journal.pone.0184987","article-title":"Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle","volume":"12","author":"Renna","year":"2017","journal-title":"PLoS ONE"},{"key":"B153","doi-asserted-by":"publisher","first-page":"e0214254","DOI":"10.1371\/journal.pone.0214254","article-title":"Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies","volume":"14","author":"Renna","year":"2019","journal-title":"PLoS ONE"},{"key":"B154","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1034\/j.1600-0854.2001.002005303.x","article-title":"Rho proteins: linking signaling with membrane trafficking","volume":"2","author":"Ridley","year":"2001","journal-title":"Traffic"},{"key":"B155","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.mito.2017.08.004","article-title":"Different approaches to modeling analysis of mitochondrial swelling","volume":"38","author":"Javadov","year":"2017","journal-title":"Mitochondrion"},{"key":"B156","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ceca.2017.06.007","article-title":"VDAC1 functions in Ca2+ homeostasis and cell life and death in health and disease","volume":"69","author":"Shoshan-Barmatz","year":"2017","journal-title":"Cell Calcium"},{"key":"B157","doi-asserted-by":"publisher","first-page":"39469","DOI":"10.18632\/oncotarget.5783","article-title":"Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats","volume":"6","author":"Javadov","year":"2015","journal-title":"Oncotarget"},{"key":"B158","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/phrev.phrev_41_16","article-title":"Targeting mitochondrial dysfunction for the treatment of diabetic complications: pharmacological interventions through natural products","volume":"11","author":"Kaikini","year":"2017","journal-title":"Pharmacogn Rev"},{"key":"B159","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1128\/MCB.23.16.5489-5501.2003","article-title":"Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization","volume":"23","author":"Wansink","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca","year":"2008","journal-title":"FEBS Lett"},{"key":"B161","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/0971-5916.93435","article-title":"Association of TNF-alpha with insulin resistance in type 2 diabetes mellitus","volume":"135","author":"Swaroop","year":"2012","journal-title":"Indian J Med Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnmol.2013.00057","article-title":"Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy","volume":"6","author":"Caillet-Boudin","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"B163","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fncel.2019.00017","article-title":"The link between tau and insulin signaling: implications for Alzheimer's disease and other tauopathies","volume":"13","author":"Goncalves","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B164","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/jpet.102.041343","article-title":"Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1","volume":"304","author":"De Luca","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"B165","doi-asserted-by":"publisher","first-page":"e1003043","DOI":"10.1371\/journal.pgen.1003043","article-title":"Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus","volume":"8","author":"Huguet","year":"2012","journal-title":"PLoS Genet"},{"key":"B166","doi-asserted-by":"publisher","first-page":"8286248","DOI":"10.1155\/2017\/8286248","article-title":"Different effects of insulin-like growth factor-1 and insulin-like growth factor-2 on myogenic differentiation of human mesenchymal stem cells","volume":"2017","author":"Aboalola","year":"2017","journal-title":"Stem Cells Int"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01229\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T05:52:41Z","timestamp":1574747561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01229\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":166,"alternative-id":["10.3389\/fneur.2019.01229"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01229","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"article-number":"1229"}}